Indoco Remedies Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹467.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.71 per cent from ₹475.61 crore. This corresponds to a year-on-year *(YoY) growth of 6.33 per cent.
Operating Profit
Operating Profit stands at ₹41.02 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.48 per cent from ₹49.71 crore. This corresponds to a year-on-year *(YoY) growth of 134.00 per cent.
PBDT
PBDT stands at ₹112.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,398.66 per cent from ₹7.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,712.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹77.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 410.88 per cent from ₹-25.00 crore. This corresponds to a year-on-year *(YoY) growth of 312.00 per cent.
Net Profit
Net Profit stands at ₹65.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 376.35 per cent from ₹-23.68 crore. This represents a 280.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd News
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | -0.05% | -0.38% | -14.82% | 1.00% | 5.50% | -22.10% |
| Venus Remedies | -0.95% | -2.95% | -10.81% | 58.62% | 106.67% | 222.94% |
| Hester Bios | -1.39% | -0.93% | 14.68% | 39.09% | 56.30% | 25.30% |
| Fredun Pharma | 1.83% | 18.23% | 44.49% | 48.07% | 109.36% | 255.51% |
| Ind-Swift Labs. | 1.49% | 0.24% | -7.28% | 65.01% | 67.00% | 120.51% |
| Windlas Biotech | 0.99% | 1.75% | 6.49% | 10.48% | 3.83% | -5.81% |
| Shukra Pharma. | 7.28% | 29.14% | 13.32% | 22.50% | -16.56% | 112.64% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Non-Exec & Non-Independent Dir : Anand Nadkarni
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN